msilverman@cooley.com
Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.
Download full bio
Amazon to Acquire One Medical for $3.9 Billion
Digital Shadows Agrees to Sell to ReliaQuest
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion
NeoPhotonics Agrees to Sell to Lumentum for $918 Million
View all
Mergers & Acquisitions
Film, Music, Surfing and Travel
Fordham University School of Law JD, cum laude, 2012
University of VermontBA, Economics and Political ScienceHonors Program, 2006
California
New York
Amazon to Acquire One Medical for $3.9 Billion July 27, 2022
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion June 3, 2022
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion December 15, 2021
+1 858 550 6152
Locations